(Reuters) – British medical devices firm ConvaTec reported an 8% increase in annual operating profit for last year, helped by an increase in margins that was ahead of target. ConvaTec shares traded up 6.4% at 259p at 0930 GMT, having earlier hit their highest level since the company floated at a price of 225p in […]
ConvaTec
Wound care giant Convatec prices $1.8B IPO
Danish wound care and colostomy supply maker ConvaTec today priced an initial public offering that grossed nearly $1.8 billion on the London Stock Exchange. ConvaTec, which is owned by private equity firms Avista Capital Partners and Nordic Capital, said it put up 33.8% of its shares in the flotation, which could rise to 38.9% if the underwriters fully exercise an over-allotment […]
ConvaTec IPO could fetch nearly $2B
ConvaTec said today that it plans to raise about $1.8 billion in an initial public offering on the London Stock Exchange in the largest U.K. flotation this year, even as Great Britain prepares to exit the European Union. The Danish wound dressing and colostomy supply maker, which is owned by private equity firms Avista Capital Partners and Nordic Capital, […]
Report: ConvaTec preps $1B IPO
ConvaTec is reportedly seeking investment banks to hire underwriters for an initial public offering that could raise more than $1 billion. The Luxembourg-based medical device company, which makes products for wound care, ostomy care and infusion, is owned by private equity firms Avista Capital Partners and Nordic Capital. Citing “people familiar with the matter,” Reuters reported that ConvaTec […]
Shockwave Medical raises $40 million for its ‘lithoplasty’ system | Medtech funding for the week of May 18, 2015
ConvaTec plans $1.9B refi
ConvaTec, which just named a new CEO and is rumored to be up for sale, plans to raise nearly $1.9 billion in loan and credit facilities in a debt-refinancing move.
ConvaTec makes interim chief Moraviec CEO | Personnel Moves
ConvaTec, which is rumored to be exploring a sale, said yesterday that it made its interim CEO, former EMEA president Paul Moraviec, to be its new permanent CEO.
Luxembourg-based ConvaTec, which is owned by private equity firms Avista Capital Partners and Nordic Capital, tapped Moraviec to lead its business in Europe, the Middle East and Africa in 2009.
DexCom elevates COO Sayer, Gregg to chairman | Personnel Moves
JNJ/Synthes integration continues to bring hefty charges | The week in medtech M&A
Kimberly-Clark plans to spin out Halyard Health as a separately traded company | Medtech Wall Street news for the week of October 13, 2014
ConvaTec owners appoint banks to explore sale: sources
(Reuters) – ConvaTec‘s owners have appointed Morgan Stanley and Goldman Sachs to explore a sale of the medical device maker which could be worth up to $10 billion, sources familiar with the matter said.